XERS - Xeris stock jumps 14% on Phase 2 data for injected levothyroxine
2024-05-30 10:29:56 ET
More on Xeris Pharmaceuticals
- Xeris Biopharma Holdings, Inc. (XERS) Q1 2024 Earnings Call Transcript
- Xeris Biopharma: Checking-In On One Of My 'Top Ideas'
- Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript
- Xeris Pharmaceuticals Q1 2024 Earnings Preview
- Xeris gains as Oppenheimer highlights drug technology